WW International, Inc. (WW)
| Market Cap | 10.42M |
| Revenue (ttm) | 785.92M |
| Net Income (ttm) | -345.70M |
| Shares Out | 80.13M |
| EPS (ttm) | -4.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,974,610 |
| Open | 0.1521 |
| Previous Close | 0.1550 |
| Day's Range | 0.1308 - 0.1567 |
| 52-Week Range | 0.1500 - 2.3500 |
| Beta | 1.70 |
| Analysts | Buy |
| Price Target | 3.44 (+2,529.97%) |
| Earnings Date | May 1, 2025 |
About WW
WW International, Inc. engages in the provision of weight management products and services in the United States, Germany, and internationally. It provides various nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also offers various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and s... [Read more]
Financial Performance
In 2024, WW International's revenue was $785.92 million, a decrease of -11.65% compared to the previous year's $889.55 million. Losses were -$345.70 million, 208.0% more than in 2023.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for WW stock is "Buy." The 12-month stock price forecast is $3.44, which is an increase of 2,529.97% from the latest price.
News
WeightWatchers bankruptcy: WW stock plunges as company reportedly considers Chapter 11
Yesterday was a head-spinning day in the markets. After President Donald Trump announced out of the blue that he would be placing a 90-day pause on reciprocal tariffs for many countries—excluding Chin...
WeightWatchers preparing to file for bankruptcy: report
Oprah Winfrey left the diet company's board last year after admitting to using a weight-loss drug.
WeightWatchers prepares for bankruptcy, WSJ reports
WeightWatchers is preparing to file for bankruptcy in the coming months as part of a plan to hand control of the business to its creditors, the Wall Street Journal reported on Wednesday, citing people...
WeightWatchers Prepares for Bankruptcy
The health and wellness company is preparing to file for bankruptcy in the coming months as part of a plan to hand control of the business to its creditors.
WeightWatchers Investor Launches Fight for Board Seats
Company's stock has fallen with competition intensifying from telehealth providers of GLP-1 drugs.
WW International, Inc. (WW) Q4 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants David Helderman - Director, Investor Relations Tara Comonte - President & Chief E...
WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results
Fourth Quarter 2024 Financial Highlights Total End of Period Subscribers of 3.3 million, including 92 thousand End of Period Clinical Subscribers Revenues of $184.4 million; Subscription Revenues down...
WW International, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the fourth quarter and full year 2024 ended Dece...
WeightWatchers and lender advisors enter confidential talks for restructuring
The Wall Street Journal reported, citing unnamed sources, that WeightWatchers and the lender advisers recently entered into a confidentiality agreement.
WeightWatchers Unveils Next-Gen Program With AI-Powered App Features
With access to Registered Dietitians, 150+ New ZeroPoint® Foods and smarter tracking features, the new program delivers a cutting-edge, flexible approach to holistic weight management With access to R...
More turnover at the top, but this bull still believes in the Weight Watchers parent
D.A. Davidson reckons WW is a buy as its customers need more than a prescription.
WW International, Inc. Announces CFO Transition
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of Felicia DellaFortuna as Chief Financial Of...
WW International, Inc. (WW) Q3 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ET Company Participants David Helderman - Vice President, Investor Relations Tara Comonte - Interim Preside...
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wed...
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs, a move that sent its shares soa...
WW Stock Rises as WeightWatchers Expands Drug Offerings
Shares of WW International Inc (WW, Financial) soared by 43.09% today due to the company's strategic move to expand its clinical weight management services. This expansion includes the introduction of...
WW International (WW) Surges After Adding Semaglutide to Weight Loss Program
WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%.
WW International (WW) Surges After Introducing Compounded Semaglutide to Weight Loss Plans
WW International (WW, Financial), a provider of weight loss solutions, experienced a significant stock movement with an initial surge of over 46.5%, which later narrowed to around a 25% increase, reac...
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering
Shares of WW International (WW), better known as WeightWatchers, jumped nearly 25% Tuesday when the dieting services company announced it is offering a copycat version of blockbuster weight-loss drugs...
WeightWatchers' stock soars after adding compounded GLP-1 treatment to its offering
“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executi...
WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
WeightWatchers said on Tuesday it is adding a compounded version of Novo Nordisk's obesity drug Wegovy to its weight-management programs.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers CEO Sima Sistani is leaving the company
WeightWatchers CEO Sima Sistani is leaving the company after two and a half years. During that time, the company has radically altered its business model to stay competitive in the Ozempic era.
WW Parts Ways With President, CEO Sima Sistani
The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.